Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/06 → 4/30/09 |
Funding
- Eli Lilly and Company: $8,931.00
A Randomized Phase 3 Trail of Alimta (Pemetrexed) and Carboplatin vs Etoposide and Carboplatin in Extensive-stage Small Cell Lung Cancer
- Arnold, Susanne M (PI)